Clinical Trial Update: SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study

View source ↗

Summary

A nationwide observational cohort study evaluating outcomes of SGLT2 inhibitor use after acute myocardial infarction in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Yonsei University | Conditions: Acute Myocardial Infarction (AMI), Type 2 Diabetes Mellitus (T2DM) | Status: ACTIVE_NOT_RECRUITING